|
ATGP1490-250ug
|
NKMax Bio (ATGen)
|
Antigen 85A [43-338 a.a.], Recombinant Protein
|
Mycobacterium tuberculosis
|
SDS-PAGE
|
|
|
ATGP1490-50ug
|
NKMax Bio (ATGen)
|
Antigen 85A [43-338 a.a.], Recombinant Protein
|
Mycobacterium tuberculosis
|
SDS-PAGE
|
|
|
HY-109588-1mg
|
MedChemexpress LLC
|
NITD-349 [CAS 1473450-62-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-109588-10mg
|
MedChemexpress LLC
|
NITD-349 [CAS 1473450-62-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-109588-100mg
|
MedChemexpress LLC
|
NITD-349 [CAS 1473450-62-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-109588-5mg
|
MedChemexpress LLC
|
NITD-349 [CAS 1473450-62-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-109588-50mg
|
MedChemexpress LLC
|
NITD-349 [CAS 1473450-62-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-109588-1mL
|
MedChemexpress LLC
|
NITD-349 [CAS 1473450-62-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-N3075-1g
|
MedChemexpress LLC
|
Phytol [CAS 150-86-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-N3075-1mL
|
MedChemexpress LLC
|
Phytol [CAS 150-86-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-125941-10mg
|
MedChemexpress LLC
|
PNU-101603 [CAS 168828-60-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-125941-25mg
|
MedChemexpress LLC
|
PNU-101603 [CAS 168828-60-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-125941-5mg
|
MedChemexpress LLC
|
PNU-101603 [CAS 168828-60-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-135748A-1mg
|
MedChemexpress LLC
|
Poly (I:C):Kanamycin (1:1) (sodium)
|
|
|
|
|
HY-135748A-10mg
|
MedChemexpress LLC
|
Poly (I:C):Kanamycin (1:1) (sodium)
|
|
|
|
|
HY-135748A-25mg
|
MedChemexpress LLC
|
Poly (I:C):Kanamycin (1:1) (sodium)
|
|
|
|
|
HY-135748A-5mg
|
MedChemexpress LLC
|
Poly (I:C):Kanamycin (1:1) (sodium)
|
|
|
|
|
HY-156421-10mg
|
MedChemexpress LLC
|
QST4 [CAS 2991427-35-9]
|
|
|
|
|
HY-156421-5mg
|
MedChemexpress LLC
|
QST4 [CAS 2991427-35-9]
|
|
|
|
|
HY-134940-10mg
|
MedChemexpress LLC
|
Quabodepistat [CAS 1883747-71-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-134940-100mg
|
MedChemexpress LLC
|
Quabodepistat [CAS 1883747-71-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-134940-25mg
|
MedChemexpress LLC
|
Quabodepistat [CAS 1883747-71-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-134940-5mg
|
MedChemexpress LLC
|
Quabodepistat [CAS 1883747-71-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-134940-50mg
|
MedChemexpress LLC
|
Quabodepistat [CAS 1883747-71-4]
|
|
COVID-19-immunoregulation
|
|
|
HY-134940-1mL
|
MedChemexpress LLC
|
Quabodepistat [CAS 1883747-71-4] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
